A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy

A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy

Abstract Introduction Evidence on health-related quality of life (HRQoL) outcomes is limited for new antiretroviral therapies (ART). Dolutegravir-based treatment is being rolled out as the preferred first-line treatment for HIV in many low- and middle-income countries. We compared HRQoL between trea...

Full description

Bibliographic Details
Main Authors: Perez Nicholas Ochanda, Mohammed Lamorde, Kenneth Kintu, Duolao Wang, Tao Chen, Thokozile Malaba, Landon Myer, Catriona Waitt, Helen Reynolds, Saye Khoo
Format: Article
Language:English
Published: BMC 2022-06-01
Series:AIDS Research and Therapy
Subjects:
HRQoL
Dolutegravir
Pregnancy
Women
HIV
ART
Online Access:https://doi.org/10.1186/s12981-022-00446-3

Internet

https://doi.org/10.1186/s12981-022-00446-3

Similar Items